Hope to see drug candidate NVG-291 help paralyzed people walk again. If you watch no other video about NVG-291, watch this one: https://xitter.gq/t.co/Sr590fFoRz
Brazil
Joined August 2009
- Tweets1.4K
- Following823
- Followers116
- Likes5.8K
Pinned Tweet
🚨ATTENTION: This is NervGen, a clinical-stage biopharma company that may have discovered a treatment for paralysis, alzheimers, and other nervous system disorders. Check out the science at NervGen.com #sci #neuralink #NVG291 $ngen
BigPowerfade retweeted
Niko was left quadriplegic after a car accident. He lost hand, triceps, bowel, bladder and sexual function, facial movement, and blood pressure and temperature regulation.
After taking $NGEN’s NVG-291 peptide for 12 weeks, he reportedly regained much of that function.
Bio/Acc. Disclaimer: I don't have a position on $NGEN.
BigPowerfade retweeted
The count down begins!
Today, we announced that the first participant has been dosed in RESTORE, our Phase 3 registrational study evaluating NVG-291 in chronic spinal cord injury.
Read more:
nervgen.com/nervgen-announce…
#SCI #SpinalCordInjury
BigPowerfade retweeted
🚨 BIG NEWS for the spinal cord injury community!
NervGen is finally recruiting for its P3 clinical trial of NVG-291! 🙌🙏🏼
If you or someone you know is living with a spinal cord injury, visit ClinicalTrials.gov to learn more and see if you may qualify.
#SCI #SpinalCordInjury #NVG291 #NervGen $NGEN
BigPowerfade retweeted
A great opportunity to hear directly from the NervGen team about their research, clinical programs, and what’s ahead for NVG-291. $NGEN
BigPowerfade retweeted
NervGen Restore Phase III trial will be starting 9/23/26! clinicaltrials.gov/study/NCT…
@FDA @NervgenP #NVG291 $NGEN
BigPowerfade retweeted
🚨 Phase 3 RESTORE trial for NervGen’s NVG-291 just hit another milestone!
Shepherd Center has posted the study — first major U.S. site is now in start-up for chronic tetraplegia (cervical SCI).
Recruitment is “Coming Soon” (targeted mid-2026), but you can already submit the interest form to be notified when screening opens:
👉 forms.cloud.microsoft/r/HNiE…
Huge step toward restoring hand function and independence after SCI.
Follow @NervGen for updates and check nervgen.com.
#SCI #SpinalCordInjury #NVG291 #NervGen #NeuroRepair #RESTOREtrial $NGEN
BigPowerfade retweeted
🚨 After 20+ years of dead ends, we’re FINALLY this close to the first-ever drug for spinal cord injury.
NervGen’s NVG-291 just cleared its End-of-Phase 2 FDA meeting. Phase 3 (RESTORE) launches mid-2026.
No approved repair therapy exists today — not stem cells, not anything. But NVG-291 data showed real, lasting gains in hand function, mobility, bladder control, and independence that kept improving after treatment stopped!
It’s just a peptide. Fast Track + Orphan Drug status.
Timeline: Phase 3 data ~2028 → possible approval in under 3 years.
Next targets: stroke, MS, hearing loss.
Why the silence? Small biotech, not flashy headlines. But this is the closest we’ve ever been.
SCI community — this one’s for you. Spread it. $NGEN #NervGen #NVG291 #SpinalCordInjury #NeuroRepair
BigPowerfade retweeted
825% Hand Improvement? NervGen NVG-291 SCI Final Results Are In. Plus P... youtu.be/XXZp87XOXZc?si=Cq1g… via @YouTube @US_FDA @DrMakaryFDA #AcceleradedApproval #SCI
BigPowerfade retweeted
After 25+ years paralyzed from a car accident, I’ve seen the “mice walking” headlines for decades. This is different — REAL results in PEOPLE. NVG-291 from NervGen Pharma (developed at Case Western Reserve incubator) is helping spinal cord injury patients open their hands, walk short distances, regain arm/leg function & independence. Phase 2 success is here! Article: cleveland19.com/2026/04/13/s… FDA — approve this ASAP. We’ve waited long enough! #CureParalysis #SCI #NVG291 @US_FDA @DrMakaryFDA
BigPowerfade retweeted
youtu.be/7CI3H-HDtgU?t=8071 CEO of NervGen $NGEN at SCI convention , very well received. The video is qued to where starts, after he is done forward to 2:39 where the mother of a patient in the NVG-291 medical study points out he went not being able to start a step to walking in 8 weeks on the drug. She begs the FDA representive to look into this, because this fact was not allowed to be reported in the study. The study was successful even with this fact not being reported. This drug should be approved now, if anyone has any way to contact RFK please get this video to him. I believe he will get it approved if he knows about it. CEO Adams answers questions till the end of that video.
Day 50 of trying to get Elon Musk to buy NervGen Pharma to add to Neuralink's treatment options for spinal cord injury. Time to steamroll paralysis! Well that ends my 50 day personal campaign. Perhaps I'll try again some other time. Thanks for all the likes. #nvg291 #elonmusk #neuralink #nvg300
Day 49 of trying to get Elon Musk to buy NervGen Pharma to add to Neuralink's treatment options for spinal cord injury. #nvg291 #elonmusk #neuralink #nvg300
Day 48 of trying to get Elon Musk to buy NervGen Pharma to add to Neuralink's treatment options for spinal cord injury. #nvg291 #elonmusk #neuralink #nvg300
BigPowerfade retweeted
NervGen’s CEO, Dr. Adam Rogers, joined @biotechnation to share the story behind NVG-291, from Dr. Jerry Silver’s pioneering research and Harold Punnett’s founding vision to what NervGen’s CONNECT SCI clinical data now shows is possible for individuals living with chronic spinal cord injury.
biotechnation.com/episodes/r…
#SCI #SpinalCordInjury
Day 47 of trying to get Elon Musk to buy NervGen Pharma to add to Neuralink's treatment options for spinal cord injury. Who can resist a narwhal? #nvg291 #elonmusk #neuralink #nvg300